| Particulars |
|
|
|
| Company Name
| Emcure Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
189.56 |
B.V. (₹) |
169.50 |
| Sales(₹ Cr.) |
4,381.92 |
NP (₹ Cr.) |
288.59 |
| NP Var (%) |
78.00 |
Div% |
30.00 |
| CPS(₹) |
27.10 |
EPS (₹) |
15.20 |
| Traded Value(₹ Lakhs) |
324.96 |
52 Week High |
1,525.00 |
| 52 Week Low |
890.00 |
Price BSE |
1,423.00 |
| Price NSE |
1,422.00 |
Market Capital (₹ Cr.) |
26,974.13 |
| P/C Ratio |
52.50 |
P/E Ratio |
93.50 |
| Price Vs.BV |
8.40 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
1,260.60 |
| NP(₹ Cr.) |
117.62 |
NP Var % |
35.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
3,847.63 |
| OPM |
12.80 |
NP |
232.25 |
| NP Var (%) |
103.92 |
EPS |
22.83 |
| PE |
62.33 |
|
|